Product Name | MF | CAS | Details |
---|
Avanafil | C23H26ClN7O3 | 330784-47-9 | Details |
(S)-[(1S,2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol | C19H22N2O | 118-10-5 | Details |
Gemcitabine | C9H11F2N3O4 | 95058-81-4 | Details |
E-7046 | C22H18F5N3O4 | 1369489-71-3 | Details |
kd-025 | C26H24N6O2 | 911417-87-3 | Details |
pimavanserin | C25H34FN3O2 | 706779-91-1 | Details |
Benztropine mesylate | C22H29NO4S | 132-17-2 | Details |
4-hydroxy-2-methoxy-benzaldehyde | C8H8O3 | 18278-34-7 | Details |
Vortioxetine | C18H22N2S | 508233-74-7 | Details |
Clemastine fumarate | C25H30ClNO5 | 14976-57-9 | Details |
BLU-9931 | C26H22Cl2N4O3 | 1538604-68-0 | Details |
Cobimetinib | C21H21F3IN3O2 | 934660-93-2 | Details |
AP26113 | C26H34ClN6O2P | 1197958-12-5 | Details |
Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
ABBV-744 | C28H30FN3O4 | 2138861-99-9 | Details |
flibanserin | C20H21F3N4O | 167933-07-5 | Details |
Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
erlotinib | C22H23N3O4 | 183321-74-6 | Details |
AQW-051 | C19H22N2O | 669770-29-0 | Details |
Siponimod | C29H35F3N2O3 | 1230487-00-9 | Details |
methyl (4R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(methoxymethoxy)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate | C27H42O5 | 610313-90-1 | Details |
tert-butyl 2-[(5-fluoro-2-pyridyl)oxymethyl]-8-azabicyclo[3.2.1]octane-8-carboxylate | C18H25FN2O3 | 2007919-75-5 | Details |
GS 5734 | C27H35N6O8P | 1809249-37-3 | Details |
NSC 60534 | C4H6O3 | 3041-16-5 | Details |
Bempedoic acid | C19H36O5 | 738606-46-7 | Details |
DTBQ | C14H20O2 | 3383-21-9 | Details |
NSC 39655 | C12H11NO | 2688-84-8 | Details |
Riociguat | C20H19FN8O2 | 625115-55-1 | Details |
PF-06840003 | C12H9FN2O2 | 198474-05-4 | Details |
PF-04447943 | C20H25N7O2 | 1082744-20-4 | Details |
Reldesemtiv | C19H18F2N6O | 1345410-31-2 | Details |
pilaralisib | C25H25ClN6O4S | 934526-89-3 | Details |
PRT 062607 | C21H27N9O3 | 1370261-98-5 | Details |
Tofacitinib | C16H20N6O | 477600-75-2 | Details |
2-[4-(3-methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide | C22H21F3N4O2 | 1146395-46-1 | Details |
TCMDC 123865 | C24H28N8O4 | 102839-00-9 | Details |
PLX-4720 | C17H14ClF2N3O3S | 918505-84-7 | Details |
Riluzole | C8H5F3N2OS | 1744-22-5 | Details |
Encenicline enantiomer | C16H18Cl2N2OS | 550999-76-3 | Details |
N-[cis-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclobutyl]propane-1-sulfonamide | C14H21N5O2S | 1622902-68-4 | Details |
Aficamten | C18H19N5O2 | 2364554-48-1 | Details |
Acalabrutinib | C26H23N7O2 | 1420477-60-6 | Details |
N-[2-[(3S)-3-[[cis-4-hydroxy-4-(5-pyrimidin-2-yl-2-pyridyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxo-ethyl]-3-(trifluoromethyl)benzamide | C29H31F3N6O3 | 1372407-07-2 | Details |
N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide | C25H31N3O4S | 1391608-77-7 | Details |
ON-123300 | C24H27N7O | 1357470-29-1 | Details |
3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide | C21H18F3N3O3 | 2446816-88-0 | Details |
Risdiplam | C22H23N7O | 1825352-65-5 | Details |
AZD-5363 | C21H25ClN6O2 | 1143532-39-1 | Details |
Ipragliflozin | C21H21FO5S | 761423-87-4 | Details |
2-bromo-1-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | C21H33BrO2 | 1430063-93-6 | Details |
OWL 833 | C48H48F2N10O5 | 2212020-52-3 | Details |
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide | C8H12N4O5 | 36791-04-5 | Details |
1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyl-oxiran-2-yl]methyl]-1,2,4-triazole | C12H11F2N3O | 127000-90-2 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 |